This report from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth.
This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into:
Abbott
atHeart Medical
Cardia
Lifetech Scientific
Occlutech
W.L. Gore